Fundraising FoxOri Biotech
8 known investors
Find your way into Ori Biotech
Sign up to find every way you can get introduced to Ori Biotech
- Your email: who you already know at Ori Biotech, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ori Biotech team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.
Investors · 8
How we know: Amadeus Capital Partners's portfolio page · oribiotech.com · Not right? Tell us
How we know: Kindred Capital's portfolio page · Not right? Tell us
How we know: oribiotech.com · Not right? Tell us
How we know: oribiotech.com · octopusventures.com · Not right? Tell us
How we know: funding news · oribiotech.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$100M disclosed across 1 of 2 rounds · 2020–2022
- $100MSeries BJan 2022 · 5 sources
Novalis LifeSciences (lead), Amadeus Capital Partners, Chimera Abu Dhabi, Delin Ventures, Northpond Ventures, Octopus Ventures, Puhua Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Ori Biotech do?
- Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.
- Who are Ori Biotech's investors?
- Ori Biotech's investors include Amadeus Capital Partners, Kindred Capital, Novalis LifeSciences, Octopus Ventures, Delin Ventures, Northpond Ventures, Puhua Capital.
- How much funding has Ori Biotech raised?
- Ori Biotech has disclosed $100M raised across 1 of its 2 known rounds.